Showing 1 - 4 results of 4 for search 'B.A. van Oirschot', query time: 0.02s
Refine Results
-
1
Ektacytometry Analysis of Post-splenectomy Red Blood Cell Properties Identifies Cell Membrane Stability Test as a Novel Biomarker of Membrane Health in Hereditary Spherocytosis by M. C. Berrevoets, J. Bos, R. Huisjes, T. H. Merkx, B. A. van Oirschot, W. W. van Solinge, J. W. Verweij, M. Y. A. Lindeboom, E. J. van Beers, M. Bartels, R. van Wijk, M. A. E. Rab, M. A. E. Rab
Published 2021-03-01
Article -
2
P1065: CONGENITAL ERYTHROCYTOSIS DUE TO HETEROZYGOUS VARIANTS IN THE BISPHOSPHOGLYCERATE MUTASE GENE by M. J. van Dijk, B. A. van Oirschot, M. C. Stam-Slob, B. van der Zwaag, E. J. van Beers, J. J. Jans, P. van der Linden, J. M. Torregrosa Diaz, B. Gardie, F. Girodon, R. Schots, N. Thielen, R. van Wijk
Published 2022-06-01
Article -
3
P1501: FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE... by M. J. van Dijk, M. A. Rab, B. A. van Oirschot, J. Bos, C. Derichs, A. W. Rijneveld, M. H. Cnossen, E. Nur, B. J. Biemond, M. Bartels, J. J. Jans, W. W. van Solinge, R. E. Schutgens, R. van Wijk, E. J. van Beers
Published 2022-06-01
Article -
4
5589320 FOLLOW-UP RESULTS OF A PHASE 2 STUDY ASSESSING THE SAFETY AND EFFICACY OF MITAPIVAT TREATMENT, AN ORAL PYRUVATE KINASE ACTIVATOR, FOR UP TO 60 WEEKS IN SUBJECTS WITH SICKLE... by M.J. van Dijk, M.A.E. Rab, B.A. van Oirschot, J.F. Bos, C. Derichs, A.W. Rijneveld, M.H. Cnossen, E. Nur, B.J. Biemond, M. Bartels, J.J.M. Jans, W.W. van Solinge, R.E.G. Schutgens, R. van Wijk, E.J. van Beers
Published 2023-04-01
Article